Skip to main content

Anti-CTLA-4 monoclonal antibodies

What are Anti-CTLA-4 monoclonal antibodies?

Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. The complex can be recognized and destroyed by phagocytes or used for other diagnostic purposes. Anti-CTLA-4 monoclonal antibodies are directed to the inhibitory receptor CD152 (CTLA-4). They may be use to treat certain types of melanoma.

List of Anti-CTLA-4 monoclonal antibodies

View by  Generic | Brand
Drug Name Avg. Rating Reviews
ipilimumab systemic (Pro)
Brand name: Yervoy
6.6
 5 reviews
tremelimumab systemic (Pro)
Brand name: Imjudo 		No reviews
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

See also

Medical conditions treated or associated with anti-CTLA-4 monoclonal antibodies:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer